Skip to content

Mechanism and clinical application of proprioceptive vibration stimulation in the treatment of facial paralysis

Mechanism and clinical application of proprioceptive vibration stimulation in the treatment of facial paralysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006836
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-05
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial paralysis

Interventions

control group: Routine physiotherapy
experience group:Vibration proprioception stimulation therapy

Sponsors

Tsinghua University Yuquan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The clinical symptoms were screened according to the diagnostic criteria of Chinese and Western medicine, of which the diagnostic criteria of Western medicine were in accordance with the latest diagnosis of peripheral facial paralysis issued by the Neurology Branch of the Chinese Medical Association in 2016, the Guidelines for the Diagnosis and Treatment of Idiopathic Facial Paralysis in China.The diagnostic criteria of traditional Chinese medicine refer to the Criteria for the Diagnosis and Efficacy of TCM Diseases issued by the State Administration of Traditional Chinese Medicine in 1994; (2) 20~70 years old; (3) The course of disease was 6 months; (4) Grade H-B is above Grade II; (5) Informed consent to accept the test; (6) Patient compliance is good.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the above inclusion criteria; (2) Central facial palsy; (3) Hunt syndrome patients; (4) We can find the diseases with the explanation of the primary cause, such as those caused by cerebrovascular accidents, tumors, surgery, trauma or systemic diseases; (5) Patients with bilateral facial paralysis; (6) Those with other serious diseases that affect the implementation of the treatment plan, such as patients with mental illness or serious hysteria; (7) The patient or guardian is unable or unwilling to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Clinical cure rate;

Secondary

MeasureTime frame
TCM symptom score;Quality of life score;Multimodal magnetic resonance;electroencephalogram;electromyogram;

Countries

China

Contacts

Public ContactJinting Wu
75510218@qq.com15210058656

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026